My Malignant Melanoma

Saw in the New Scientist today that there are a number of really promising new drugs for MM coming through: Lambrolizumab and Nivolumab, which both work on the PD-1 receptor, and a so far unnamed drug which works on another receptor.

All give great reductions in tumour volume, and there all in all cases apparent complete cures. They all work by rebooting the immune system, in just the same way as quack diets claim to do, but actually don't.

In other news, it seems that mucosal melanoma is really a different disease from cutaneous melanoma.

Labels: boosting, immune system, Lambrolizumab, Malignant, Nivolumab. melanoma